Navigation Links
Healthesystems Appoints Dr. Robert L. Goldberg as Chief Medical Officer
Date:3/21/2013

served as President of the American College of Occupational and Environmental Medicine (ACOEM) and Vice-Chair of Occupational Medicine of the American Board of Preventive Medicine, and continues to serve both organizations. He is Professor of Medicine at the University of California, San Francisco and has over 25 years of medical management experience, having worked closely with payers, employers, third party administrators and patients.

“I am excited about the opportunity to apply my medical expertise and leadership skills to expand the clinical direction of Healthesystems,” stated Dr. Goldberg. “Healthesystems affords me the unique opportunity to leverage my significant experience across all aspects of occupational medicine and look at the entire treatment spectrum for injured workers.”

As a national leader in his field, Dr. Goldberg has been invited to speak at both international and national symposiums and conferences. He recently published and presented research findings from a national collaborative study on ergonomics and musculoskeletal disorders in workers in four industries to the American College of Occupational and Environmental Medicine (ACOEM).

Prior to joining Healthesystems, Dr. Robert Goldberg served as Chief Medical Officer for Landmark Healthcare, Inc. in which he was responsible for clinical operations and utilization management of physical medicine services.

To read more information about Dr. Goldberg, or to request his participation for speaking engagements, visit http://www.healthesystems.com/about-us/leadership-profiles/rgoldberg.aspx

About Healthesystems
Healthesystems is a specialty provider of innovative medical cost management solutions for the workers’ compensation industry. The company's comprehensive offerings include a leading Pharmacy Benefit Management (PBM) progr
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Experimental Chemo Combo for Colon Cancer Disappoints
2. Eagle Village Appoints Mike Mischley and Dani Montini to Board of Directors
3. EPC Group Appoints Industry Veteran to Lead Development Practice Expansion
4. Life Support Technologies Group Appoints Scott Gorenstein, MD as Co-Clinical Director
5. Life Support Technologies Group Appoints Edward Golembe, MD as Co-Clinical Director
6. PaloDEx Appoints Brian Broncatti to the Position of Vice President North America
7. Dynarex Corporation Appoints a New National Sales Manager to Lead their Sales Organization
8. Private Real Estate Investment Firm, Cohen Asset Management, Inc., Appoints Senior Vice President of Asset Management for East Coast
9. U.N. Secretary-General Appoints Ray Chambers as His First Special Envoy for the Financing of the Health-Related Millennium Development Goals
10. AxoGen, Inc. Appoints Shawn McCarrey as Vice President of Sales
11. ProvidaStaff, LLC Appoints a New Account Manager and Marketing Administrator to Keep Up with Demand for Healthcare Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 “ Food Cost Calculator ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... to manage and efficiently calculate food costs. , The restaurant ... fact, the industry has an estimated 1.8 trillion dollar impact ...
(Date:5/4/2015)... 2015 The Accreditation for ... first-ever congenital heart disease (CHD) standards for ... accreditation. Driven by the latest available clinical ... review of interventional procedures in pediatric patients ... “The ACE CHD Standards for PCCL Accreditation, ...
(Date:5/4/2015)... “St. Louis has long represented opportunity ... West,” so it is the perfect place for Zerorez ... Ben Litalien, Chief Development Officer for Zerorez. “We ... will provide veterans with a $10,000 discount on our ... have a number of Military Veterans in its ranks ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Sara Soulati, ... physician practice management firm in Los Angeles associated with ... the patent-pending status of The Sara Soulati Health For ... in 2010, is a lifestyle modification and disease prevention ... 2015 to the U. S. Patents and Trademarks Office ...
(Date:5/3/2015)... Barbara Crone has joined Women’s Excellence in ... of the men, women and families who seek her care, initially ... for families in the home. , “When the ... if I could complete their care with the delivery of their ... mentor Nurse Midwife, I knew it was time for me to ...
Breaking Medicine News(10 mins):Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Accreditation for Cardiovascular Excellence (ACE) Publishes New Standards for Pediatric and Adult Congenital Cardiac Catheterization Laboratories 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3Health News:CEO Sara Soulati Announces Patent-Pending Designation For The Sara Soulati Health For Life Program 2Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2
... out on the best drug treatment for their disease, because ... of print in the Archives of Disease in Childhood. ... and the disease prompts up to a third of children ... , The researchers used national data to calculate the number ...
... CINCINNATI, Sept. 3 Most children in the ... Attention Deficit,Hyperactivity Disorder (ADHD) have not been diagnosed ... medications, according to the first,national ADHD prevalence study ... criteria, according to a new study conducted by ...
... appears to be associated with adolescents risk of becoming ... in their lifetimes, according to a report in the ... one of the JAMA/Archives journals. , Previous studies have ... risk of starting to smoke, according to background information ...
... the medications they need, researchers say , , MONDAY, Sept. ... children have attention-deficit/hyperactivity disorder (ADHD), but only 32 percent ... That,s the sobering conclusion of a landmark new study, ... consider the "gold standard" of diagnostic criteria -- the ...
... Stent is Featured at ... ESC Congress 2007, ... from patient subsets of a global registry support,the use of the ... Presented today by Robbert de Winter, M.D., Ph.D., at the European,Society ...
... Cam in Cambridge, famous as a haunt of students ... become the next generation of antibiotics, according to scientists ... for General Microbiologys 161st Meeting at the University of ... With antibiotics now over-prescribed for treatments of bacterial infections, ...
Cached Medicine News:Health News:Childhood asthma still inappropriately treated in the UK 2Health News:Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New 'Gold Standard' Study by Cincinnati Children's Researchers 2Health News:Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New 'Gold Standard' Study by Cincinnati Children's Researchers 3Health News:Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New 'Gold Standard' Study by Cincinnati Children's Researchers 4Health News:Teens who see more smoking in movies may have increased risk of becoming established smokers 2Health News:9% of U.S. Kids Have ADHD 2Health News:9% of U.S. Kids Have ADHD 3Health News:Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents 2Health News:New viruses to treat bacterial diseases -- 'My enemies' enemy is my friend' 2
(Date:5/4/2015)... May 4, 2015   HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of advanced ... Godshall , is scheduled to present at the Bank of ... Las Vegas on Thursday, May 14, 2015, at ... webcast of the Company,s presentation at the conference will be ...
(Date:5/4/2015)... 4, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXI Rx ... of the agreement, Isis is eligible to receive up ... $100 million up-front payment and a $55 million payment ... study in patients with compromised kidney function. Isis is ...
(Date:5/4/2015)... , May 4, 2015 MEI Pharma, ... focused on the clinical development of novel therapies ... mitochondria-specific effects of the Company,s investigational drug candidate ... activity when combined with a tyrosine-kinase inhibitor (TKI). ... to be a potent inhibitor of mitochondrial oxidative ...
Breaking Medicine Technology:HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5
... , FRANKLIN LAKES, N.J. , ... BDX ), a leading global medical technology company, is increasing ... Haiti earthquake relief efforts from the $500,000 ... in market value of critical medical supplies.  This additional commitment will ...
... , Jan. 27 CardioGenics Holdings Inc. (OTC ... the in-vitro diagnostics segment of the Point-Of-Care (POC) diagnostic market, ... self-metering cartridge for its POC diagnostic device, the QL Care ... the self-metering cartridge. , Dr. Yahia Gawad , CEO ...
Cached Medicine Technology:BD Increases Haiti Relief Fund to Include $5 Million in Product Donations 2BD Increases Haiti Relief Fund to Include $5 Million in Product Donations 3CardioGenics Announces Completion of Cartridge Design for QL Care Analyzer 2CardioGenics Announces Completion of Cartridge Design for QL Care Analyzer 3
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
Curved shaft with flat 4.5 mm hook. Flat serrated handle with polished finish. Overall length: 5.3 inches....
Titanium. Small "H" shaped push-pull tip. Shaft angled 45 degrees, 9 mm from tip. Round knurled handle with dull finish. Overall length: 4.8 inches. Most popular size or model....
This suture adjuster facilitates post operative suture adjustment of running sutures while decreasing the possibility of suture damage or breakage....
Medicine Products: